Centene holds Q3 benefits ratio at 92.7% and trims full-year HBR guidance
Per Company Talk, Centene's health benefits ratio stayed at 92.7% in Q3 2026, level with last year, while full-year HBR guidance now sits at 90.4% to 91.1%.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Company Talk, Centene's consolidated HBR was 92.7% in the third quarter of 2026, unchanged from the same period a year earlier. The insurer credits the steady figure to its Medicare Advantage and Prescription Drug Plans units, along with better pricing and risk transfer in the Marketplace business given members' health acuity.
The main change from 2025 is that Centene no longer has to hold a reserve against expected future losses in Medicare Advantage, as that segment edges toward profit. The same reserve reduction had lifted last year's third-quarter ratio. For the full year the company now expects HBR between 90.4% and 91.1%, with the midpoint 15 basis points better at 90.75%.
why it matters
For investors, a flat benefits ratio alongside a smaller reserve need points to better margins at the insurer. A lower expected midpoint for HBR means the company anticipates lower costs over the year, which reinforces that read.
market impact
Centene shares: steady claims ratio and firmer outlook support the stock
- Centene shares pressure up — a steady benefits ratio and better guidance midpoint support margins
tags
instruments
sources
- Centene Medicare Advantage Fundamentals Outpace HBR Deficit Offset — Company Talk, 27 October 2026 at 11:27 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗